The PE Ratio as of December 2025 (TTM) for Insight Molecular Diagnostics Inc. (IMDX) is -1.74

According to Insight Molecular Diagnostics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.74. This represents a change of 588.75% compared to the average of -0.25 of the last 4 quarters.

Insight Molecular Diagnostics Inc. (IMDX) Historical PE Ratio (quarterly & annually)

How has IMDX PE Ratio performed in the past?

The mean historical PE Ratio of Insight Molecular Diagnostics Inc. over the last ten years is -5.74. The current -1.74 PE Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), IMDX's PE Ratio was at its highest in in the March 2023 quarter at 4.40. The PE Ratio was at its lowest in in the March 2021 quarter at -27.19.

Insight Molecular Diagnostics Inc. (IMDX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Insight Molecular Diagnostics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Insight Molecular Diagnostics Inc. (IMDX) Average PE Ratio

How has IMDX PE Ratio performed in the past?

The current PE Ratio of Insight Molecular Diagnostics Inc. (IMDX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Insight Molecular Diagnostics Inc. (IMDX) PE Ratio vs. Peers

How is IMDX’s PE Ratio compared to its peers?

Insight Molecular Diagnostics Inc.’s PE Ratio is less than C4 Therapeutics, Inc. (-1.58), greater than Sangamo Therapeutics, Inc. (-2.15), less than Cybin Inc. (-1.73), greater than OmniAb, Inc. (-3.55), less than Prelude Therapeutics Incorporated (-0.94), greater than Codexis, Inc. (-2.50), greater than Armata Pharmaceuticals, Inc. (-4.59), greater than Invivyd, Inc. (-6.31), greater than PepGen Inc. (-1.79), greater than Milestone Pharmaceuticals Inc. (-5.53),

Build a custom stock screener for Insight Molecular Diagnostics Inc. (IMDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Insight Molecular Diagnostics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Insight Molecular Diagnostics Inc. (IMDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Insight Molecular Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.